India

in page functions
[French]
India
Total population (2018) 1,358,103,152
Birth cohort (2018) 25,701,683
Surviving Infants (surviving to 1 year per year, 2018) 24,848,076
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 38/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 48/1000
Gross Nation Income (per capita US$, 2015) 1,600
Co-financing group (2018) Accelerated transition
No. of districts/territories (2017) 700

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for India

Type of support

Approvals

2001-2023 (US$)
(28 Nov 2018)

Commitments

2001-2023 (US$)
(28 Nov 2018)

Disbursements

2000-2018 (US$)
(28 Nov 2018)

% Disbursed

(28 Nov 2018)
2002 2003 2005 2006 2007 2009 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $859,324,988 $914,401,285 $747,119,686
Health system strengthening (HSS 1) $107,000,000 $107,000,000 $107,000,000 100%
Health system strengthening (HSS 2) $53,979,703 $100,000,000 $53,979,703 100%
HepB mono (NVS) $26,486,033 $26,486,033 $26,486,033 100%
Injection safety support (INS) $18,427,489 $18,427,489 $18,427,489 100%
IPV (NVS) $16,319,169 $16,319,169 $16,319,169 100%
Measles-Rubella (NVS) $127,341,015 $127,341,015 $125,069,438 98%
MR - Operational costs (OPC) $8,508,020 $8,508,020 $8,508,020 100%
Penta (NVS) $264,904,036 $264,904,036 $264,904,712 100%
Pneumo (NVS) $180,000,000 $180,000,000 $107,052,110 59%
Rotavirus (NVS) $55,944,000 $65,000,000 $18,957,489 34%
Vaccine Introduction Grant (VIG) $415,523 $415,523 $415,523 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

India DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 88%
M:F sex ratio at birth (2018) 1.11
Household survey: DTP3 coverage for male (2008) 71.50%
Household survey: DTP3 coverage for female (2008) 71.40%
Household survey: Last DTP3 survey (2008) 72%
% districts achieving > 80% DTP3 coverage (2017) 61%
% districts achieving < 50% DTP3 coverage (2017) 2%
MCV WHO/UNICEF estimates (2017) 88%

Breakdown of support

Non-vaccine support Vaccine support
25% 75%
$188,330,735 $558,788,951

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to India

12 December 2018

MTR HE Reem Al Hashimy

Global health leaders hail immunisation as shortest path to healthy lives

Gavi Mid-Term Review closes with commitments to accelerate immunisation programmes in the poorest countries to reach more children with lifesaving vaccines.

11 December 2018

MTR Vaccine Hero award

Serum Founder wins inaugural 'Vaccine Hero' award

Dr Cyrus Poonawalla congratulated for life-long commitment to boosting vaccine coverage in the world’s poorest countries.

05 December 2018

PMNCH Partners Forum Logo

Harnessing the power of partnerships to benefit maternal, newborn & child health

The Partners Forum for The Partnership for Maternal, Newborn & Child Health represents a landmark opportunity to push for action to improve the health and well-being of women, children and adolescents.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here